The global Cardiopulmonary Bypass Machine market size is predicted to grow from US$ 287 million in 2025 to US$ 377 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient"s blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
The Cardiopulmonary Bypass Machine market is primarily driven by the increasing prevalence of cardiovascular diseases and the growing demand for advanced surgical procedures. As heart surgeries become more intricate and the complexity of cases rises, the need for reliable and sophisticated cardiopulmonary bypass machines is on the rise. These machines play a crucial role in maintaining circulation and oxygenation during cardiac surgeries, enabling surgeons to perform intricate procedures with precision. Moreover, technological advancements have led to the development of innovative features in these machines, such as improved monitoring, minimized blood trauma, and reduced risk of complications. However, the market also faces challenges, including the high cost of these machines and the need for skilled healthcare professionals to operate them effectively. Regulatory compliance and safety considerations also present challenges for manufacturers. To succeed, stakeholders must focus on continuous innovation, addressing cost concerns through efficient manufacturing processes, and providing comprehensive training and support to healthcare teams. Collaborating with medical institutions to understand their specific needs and enhancing patient outcomes through improved machine performance will drive market growth and the adoption of cardiopulmonary bypass machines.
LP Information, Inc. (LPI) ' newest research report, the “Cardiopulmonary Bypass Machine Industry Forecast” looks at past sales and reviews total world Cardiopulmonary Bypass Machine sales in 2024, providing a comprehensive analysis by region and market sector of projected Cardiopulmonary Bypass Machine sales for 2025 through 2031. With Cardiopulmonary Bypass Machine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiopulmonary Bypass Machine industry.
This Insight Report provides a comprehensive analysis of the global Cardiopulmonary Bypass Machine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiopulmonary Bypass Machine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiopulmonary Bypass Machine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiopulmonary Bypass Machine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiopulmonary Bypass Machine.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiopulmonary Bypass Machine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Single Roller Pump
Double Roller Pump
Segmentation by Application:
Cardiac Surgery
Lung Transplant Operation
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
LivaNova
Getinge
Medtronic
Terumo
Braile Biomedica
Tianjin Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cardiopulmonary Bypass Machine market?
What factors are driving Cardiopulmonary Bypass Machine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cardiopulmonary Bypass Machine market opportunities vary by end market size?
How does Cardiopulmonary Bypass Machine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook